Ionis Pharmaceuticals IONS Earnings per common share - diluted (in dollars per share)
Earnings per common share - diluted (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share)?
- Ionis Pharmaceuticals (IONS) reported earnings per common share - diluted (in dollars per share) of -$0.56 in Q1 2026.
- How has Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share) changed year-over-year?
- Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share) increased by 39.8% year-over-year, from -$0.93 to -$0.56.
- What is the long-term trend for Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's earnings per common share - diluted (in dollars per share) has grown at a 59.2% compound annual growth rate (CAGR), from -$0.38 to -$2.44.
- What does earnings per common share - diluted (in dollars per share) mean?
- Calculates the portion of a company's profit allocated to each share of common stock, assuming all convertible securities and stock options are exercised. This provides a conservative view of earnings per share by accounting for potential dilution.